Related Experiment Videos
Diagnosis of hepatitis C
1Second Department of Internal Medicine, National Defense Medical College, Saitama, Japan.
Insights
Detecting hepatitis C virus RNA and antibodies aids in diagnosing, assessing, and predicting outcomes. These methods help differentiate acute infections and identify past versus current hepatitis C virus (HCV) cases.
Area of Science:
- Hepatology and Virology
- Clinical Diagnostics
Background:
- Hepatitis C virus (HCV) infection poses significant diagnostic and prognostic challenges.
- Accurate assessment is crucial for effective patient management and treatment strategies.
- Established diagnostic markers require evaluation for specific clinical scenarios.
Purpose of the Study:
- To evaluate the clinical utility of various hepatitis C virus (HCV) markers.
- To assess the role of these markers in early diagnosis and prognosis of acute HCV.
- To differentiate acute HCV from flare-ups in carriers and distinguish past from current infections.
Main Methods:
- Detection of HCV-RNA using nested reverse transcription-polymerase chain reaction (RT-PCR).
- Quantitative assay of HCV-RNA via competitive RT-PCR.
- Qualitative and quantitative assays for anti-HCV IgG and IgM antibodies.
- Identification of HCV viral type (genotype and serological group).
Main Results:
- Developed methods include HCV-RNA detection and quantification, antibody assays, and viral typing.
- Evaluated clinical utility for early diagnosis, prognosis, and differentiating infection statuses.
- Assessed marker performance in acute hepatitis C, HCV carrier flare-ups, and resolved infections.
Conclusions:
- HCV-RNA and antibody assays are valuable indicators for hepatitis C diagnosis, condition, and prognosis.
- These markers aid in differentiating acute hepatitis C from other conditions.
- The evaluated methods assist in distinguishing between past and current HCV infections.
Abstract:
As indicators to determine the diagnosis, condition, and prognosis of hepatitis C, methods have been developed such as the detection of HCV-RNA by the nested RT-PCR method, quantitative assay of HCV-RNA by the competitive RT-PCR method, qualitative and quantitative assay of various anti-HCV IgG and IgM antibodies, and identification of viral type (genotype and serological group). The clinical utility of these HCV markers in early diagnosis and prognosis of acute hepatitis C, for differentiating it from acute flare in HCV carriers, and in distinguishing between past and current infection in second-generation-anti-HCV-positive patients with normal serum alanine aminotransferase has been evaluated.